Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Biodelivery Sci Intl (BDSI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 121,726
  • Shares Outstanding, K 55,330
  • Annual Sales, $ 15,550 K
  • Annual Income, $ -67,140 K
  • 36-Month Beta 1.17
  • Price/Sales 7.83
  • Price/Cash Flow 0.00
  • Price/Book 3.16

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.65 +45.45%
on 05/03/17
2.55 -5.88%
on 05/22/17
+0.70 (+41.18%)
since 04/26/17
3-Month
1.55 +54.84%
on 04/19/17
2.55 -5.88%
on 05/22/17
+0.52 (+27.66%)
since 02/24/17
52-Week
1.50 +60.00%
on 11/23/16
3.10 -22.58%
on 07/12/16
+0.31 (+14.83%)
since 05/26/16

Most Recent Stories

More News
BioDelivery Sciences International (BDSI) Jumps: Stock Up 5%

BioDelivery Sciences International, Inc. (BDSI) shares rose over 5% in the last trading session.

AKTX : 6.61 (-1.20%)
BDSI : 2.40 (+9.09%)
BioDelivery (BDSI) Q1 Earnings Beat Estimates, Stock Gains

BioDelivery Sciences International, Inc. (BDSI) reported earnings of 58 cents per share in the first quarter of 2017, which comfortably beat the Zacks Consensus Estimate of 9 cents.

AGLE : 4.50 (+1.58%)
ENDP : 13.12 (+1.78%)
VVUS : 1.13 (+0.89%)
BDSI : 2.40 (+9.09%)
Investor Network: BioDelivery Sciences International, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 15, 2017 / BioDelivery Sciences International, Inc. (NASDAQ: BDSI) will be discussing their earnings results in their Q1 Earnings Call to be held May 15, 2017 at 4:30 PM...

BDSI : 2.40 (+9.09%)
BioDelivery Sciences to Host Conference Call and Webcast Reporting First Quarter 2017 Financial Results on Monday, May 15

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it will report its first quarter 2017 financial results and host a conference call and webcast at 4:30 PM Eastern Time on Monday,...

BDSI : 2.40 (+9.09%)
What's in Store for BioDelivery (BDSI) this Earnings Season?

BioDelivery Sciences International, Inc. (BDSI) is expected to report first-quarter 2017 results later this month. Last quarter, the company???s loss was wider than expected.

ENDP : 13.12 (+1.78%)
BDSI : 2.40 (+9.09%)
CDTX : 6.75 (+0.75%)
EDIT : 15.62 (-4.23%)
BioDelivery Sciences Announces the Approval of BUNAVAIL® for Induction of Buprenorphine Treatment for Opioid Dependence

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that the U.S. Food and Drug Administration (FDA) has approved a Supplemental New Drug Application (sNDA) for BUNAVAIL® (buprenorphine...

BDSI : 2.40 (+9.09%)
BioDelivery Sciences to Present at the Deutsche Bank 42nd Annual Health Care Conference

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer, will present at the Deutsche Bank 42nd Annual Health Care Conference. The...

BDSI : 2.40 (+9.09%)
DB : 18.46 (-2.07%)
Research Reports Coverage on Biotech Stocks -- Novan, Stemline Therapeutics, BioDelivery Sciences, and OncoGenex Pharma

On Monday, the NASDAQ Composite ended the day at 5,983.82, up 1.24%; the Dow Jones Industrial Average edged 1.05% higher, to finish at 20,763.89; and the S&P 500 closed at 2,374.15, marginally gaining...

STML : 8.45 (+1.20%)
BDSI : 2.40 (+9.09%)
NOVN : 4.92 (+1.86%)
OGXI : 0.36 (unch)
BioDelivery (BDSI) Down 15% Since Earnings Report: Can It Rebound?

BioDelivery (BDSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BDSI : 2.40 (+9.09%)
BioDelivery to Grant New Patents for its Marketed Drugs

BioDelivery Sciences (BDSI) recently announced its decision to grant two new patents to extend the patent life for all three of its marketed products, Belbuca , Bunavail, and Onsolis.

HSKA : 97.40 (-0.58%)
COL : 107.30 (+0.36%)
BDSI : 2.40 (+9.09%)
RTRX : 16.51 (-2.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

See More

Business Summary

BioDelivery Sciences International is a development-stage biotechnology company that is developing and seeking to commercialize a drug delivery technology designed for a potentially broad base of pharmaceuticals, vaccines and over-the-counter drugs. In general, a drug delivery technology refers to any...

See More

Support & Resistance

2nd Resistance Point 2.57
1st Resistance Point 2.48
Last Price 2.40
1st Support Level 2.28
2nd Support Level 2.17

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.